InspireMD (NSPR) Earnings Analysis

InspireMD (NSPR) next reports earnings on 2026-08-03, consensus EPS -0.2 USD. Last quarter (2026-05-04) it beat with EPS -0.16 USD vs -0.19 USD est (+15.8%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -1.23.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NSPR next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate-0.2 USD
Revenue estimate0.00B

NSPR earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-04-0.16 USD-0.19 USD+15.8%Beat
2026-03-18-0.14 USD-0.22 USD+36.4%Beat
2025-08-04-0.26 USD-0.24 USD-8.3%Miss
2025-05-09-0.22 USD-0.17 USD-29.4%Miss
2025-03-12-0.19 USD-0.2 USD+5%Beat

Beat rate: 3/5 (60%) over reported quarters with consensus data.

NSPR valuation and analyst view

Trailing P/E-1.23
Trailing EPS-0.50813 USD
Price / book1.17
Dividend yield0.00%
Market cap0.03B
Analyst consensusBuy (6 buy / 1 hold / 0 sell)
Avg price target3.5 USD

Related research pages

Frequently asked questions

When is InspireMD (NSPR)'s next earnings date?

InspireMD is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.2 USD and revenue estimate of 0.00B.

Did NSPR beat earnings last quarter?

In its 2026-05-04 report, NSPR posted EPS of -0.16 USD versus a -0.19 USD estimate — a beat of 15.8%.

What is NSPR's earnings track record?

Over the last 5 reported quarters with consensus data, NSPR beat estimates 3 times (60%).

What is NSPR's current P/E ratio and EPS?

NSPR trades at a trailing P/E of -1.23 on trailing EPS of -0.5081340167636721 USD.

What do analysts rate NSPR?

Analyst consensus is "Buy" across 7 ratings (0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 3.5 USD.